Trials / Conditions / Telangiectasia, Hereditary Hemorrhagic

Telangiectasia, Hereditary Hemorrhagic

21 registered clinical trials studyying Telangiectasia, Hereditary Hemorrhagic — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Efficacy of Nintedanib for Treatment of Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) Patients NCT04976036	Dr. Romain Lazor	Phase 2
Active Not Recruiting	Hereditary Hemorrhagic Telangiectasia and Neurovascular Manifestations, in the Danish HHT Database NCT05933330	Odense University Hospital	—
Completed	Efficacy of Nintedanib Per os as a Treatment for Epistaxis in HHT Disease. NCT03954782	Hospices Civils de Lyon	Phase 2
Completed	Diagnostic Value of Ultra-low Dose Thoracic Scanner for the Pulmonary Arteriovenous Malformation Detection in NCT04108052	Hospices Civils de Lyon	N/A
Completed	Pomalidomide for the Treatment of Bleeding in HHT NCT03910244	The Cleveland Clinic	Phase 2
Completed	BABH Study: Efficacy and Safety of Bevacizumab on Severe Bleedings Associated With Hemorrhagic Hereditary Tela NCT03227263	Hospices Civils de Lyon	Phase 3
Completed	Efficacy of a Timolol Nasal Spray as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) NCT02484716	Hospices Civils de Lyon	Phase 2
Terminated	Evaluation of Pazopanib on Bleeding in Subjects With Hereditary Haemorrhagic Telangiectasia NCT02204371	GlaxoSmithKline	Phase 2
Completed	Treatment of Hereditary Hemorrhagic Telangiectasia of the Nasal Mucosa by Intranasal Bevacizumab : Search for NCT02157987	University Hospital, Caen	Phase 1 / Phase 2
Completed	The ELLIPSE Study: A Phase-1 Study Evaluating the Tolerance of Bevacizumab Nasal Spray to Treat Epistaxis in H NCT01507480	Hospices Civils de Lyon	Phase 1
Completed	North American Study of Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) NCT01408030	James Gossage	Phase 2
Completed	Study of Histological Samples From Patients With Hereditary Haemorrhagic Telangiectasia NCT00733655	Imperial College London	—
Completed	Screening Behavior in Adults With Hereditary Hemorrhagic Telangiectasia NCT00684879	National Human Genome Research Institute (NHGRI)	—
Completed	ATERO : A Randomised Study With Tranexamic Acid in Epistaxis of Rendu Osler Syndrome NCT00355108	Hospices Civils de Lyon	Phase 3
Completed	Investigation of Plasma Proteins in Patients With Hereditary Haemorrhagic Telangiectasia and PAVMs NCT00230672	Imperial College London	—
Completed	Investigation of Coagulation Parameters in Hereditary Haemorrhagic Telangiectasia NCT00230659	Imperial College London	—
Withdrawn	Study of Endothelial Cells in Patients With Hereditary Haemorrhagic Telangiectasia NCT00733629	Imperial College London	—
Active Not Recruiting	Studies of White Blood Cells Derived From HHT Patients NCT00230633	Imperial College London	—
Recruiting	Case Notes Review on Patients With Hereditary Haemorrhagic Telangiectasia NCT00230685	Imperial College London	—
Recruiting	Molecular Studies on Hereditary Haemorrhagic Telangiectasia Families NCT00230620	Imperial College London	—
Completed	Studies of Hereditary Hemorrhagic Telangiectasia NCT00004648	National Center for Research Resources (NCRR)	—